Literature DB >> 8174576

Survival after postinfarction cardiac rupture in severe aortic valve stenosis.

M A Kadri1, J Kakadellis, C S Campbell.   

Abstract

Myocardial rupture is a lethal complication of acute myocardial infarction. The concurrence of myocardial infarction and hypertension is known to predispose to cardiac rupture. Therefore, it is likely that postinfarction cardiac rupture in the presence of severe aortic stenosis will lead to a rapidly fatal outcome due to the associated left ventricular hypertension. We report survival in a patient with postinfarction left ventricular free wall rupture discovered at operation for severe aortic valve stenosis.

Entities:  

Mesh:

Year:  1994        PMID: 8174576     DOI: 10.1093/oxfordjournals.eurheartj.a060368

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  Relation of left ventricular free wall rupture and/or aneurysm with acute myocardial infarction in patients with aortic stenosis.

Authors:  Irtiza N Sheikh; William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  Ruptured left ventricular pseudoaneurysm penetrating into the left pleural cavity.

Authors:  M Hamamoto; H Ogino; Y Hanafusa; S Numata; M Ando
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-09

3.  Postinfarction cardiac rupture despite immediate reperfusion therapy in a patient with severe aortic valve stenosis.

Authors:  Makiko Tanaka; Yoichi Goto; Shoji Suzuki; Isao Morii; Yoritaka Otsuka; Shunichi Miyazaki; Hiroshi Nonogi
Journal:  Heart Vessels       Date:  2006-01       Impact factor: 1.814

4.  Intraprocedural left ventricular free wall rupture diagnosed by left ventriculogram in a patient with infero-posterior myocardial infarction and severe aortic stenosis.

Authors:  Takao Konishi; Naohiro Funayama; Tadashi Yamamoto; Hiroshi Nishihara; Daisuke Hotta; Kenjiro Kikuchi; Hideo Yokoyama; Katsumi Ohori
Journal:  BMC Cardiovasc Disord       Date:  2016-06-06       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.